載入...
Non-ion channel therapeutics for heart failure and atrial fibrillation: are CaMKII inhibitors ready for clinical use?
The Ca(2+)-calmodulin dependent protein kinase II (CaMKII) is an established central mediator of electrophysiological and contractile responses to cardiac stress, and its hyper-activation in cardiac diseases has been linked to heart failure (HF) and atrial and ventricular arrhythmias. Here we summar...
Na minha lista:
| 發表在: | J Mol Cell Cardiol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6358017/ https://ncbi.nlm.nih.gov/pubmed/29079077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2017.10.010 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|